July 08, 2024 11:45 AM Eastern Daylight Time

Genentech to Reintroduce Susvimo for People With Wet Age-related Macular Degeneration (AMD)

View Full Size

Download

Full Size JPEG, 1140x1140, 129.7 KB
Small JPEG, 480x480, 46.3 KB
Preview JPEG, 144x144, 8.5 KB
Thumbnail JPEG, 70x70, 3.6 KB

Smart Multimedia Gallery

Susvimo, developed by Genentech, a member of the Roche Group, is a refillable eye implant that continuously delivers a customized formulation of ranibizumab over time. (Photo: Business Wire)

View and Share Photo

Download Full Size
Download Small

http://www.businesswire.com/multimedia/syndication/20240703748120/en/5677472/Genentech-to-Reintroduce-Susvimo-for-People-With-Wet-Age-related-Macular-Degeneration-AMD

Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark

All News | News with Multimedia > Press Release: Genentech to Reintroduce Susvimo for People Wit...